Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/777
PESQUISAS BRASILEIRAS BIOMÉDICAS E EPIDEMIOLÓGICAS FACE ÀS METAS DA UNGASS
Prevenção e controle
Epidemiologia
Vacinas contra Aids
Desenvolvimento tecnológico
Tendências
Tecnologia biomédica
Resistência viral a drogas
Acquired immunodeficiency syndrome
Epidemiology
AIDS vaccines
Technological development trends
Biomedical technology trends
Drug resistance viral
Alternative title
Brazilian biomedical and epidemiological research vis-à-visthe UNGASS targetsAffilliation
Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Departamento de Informações em Saúde. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Departamento de Informações em Saúde. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Departamento de Informações em Saúde. Rio de Janeiro, RJ, Brasil.
Abstract in Portuguese
The focus of the present study is the Brazilian response within science, technology and innovation to the targets formulated in the UNGASS document. An analysis was made of items 70-73 of the UNGASS Draft Declaration of Commitment on HIV/ AIDS (2001), which defined science, technology and innovation targets relating to HIV/AIDS. The main topics listed in these items were put into operation in the form of keywords, in order to guide systematic searches within the standard biomedicine databases, also including the subdivisions of the Web of Science relating to natural and social sciences. The success of Brazilian research within the field of characterization and isolation of HIV-1 is undeniable. Phase II/III vaccine studies have been developed in Rio de Janeiro, Belo Horizonte and São Paulo. Empirical studies on the monitoring
of primary resistance have been developed in specific populations, through the Brazilian HIV Resistance Monitoring Network. Within the field of monitoring secondary resistance, initiatives such as the National Genotyping Network have been highlighted. Two national systems – the Mortality Information System and the Notifiable Diseases Information System (AIDS) – and some studies with wider coverage have given rise to work on trends within the epidemic. The production of high-quality generic medications and their free distribution to patients have been highlighted. Brazil has implemented a consistent and diversified response within the field of HIV/AIDS, with studies relating to the development of vaccines, new medications and monitoring of the epidemic.
Keywords in Portuguese
Síndrome de imunodeficiência adquiridaPrevenção e controle
Epidemiologia
Vacinas contra Aids
Desenvolvimento tecnológico
Tendências
Tecnologia biomédica
Resistência viral a drogas
Keywords
Prevention & controlAcquired immunodeficiency syndrome
Epidemiology
AIDS vaccines
Technological development trends
Biomedical technology trends
Drug resistance viral
Share